Ergonomics is a term dating only as far back as the 1940s. It well describes the science of adapting work and working conditions to suit the worker instead of the other way around - the worker adapting to the machine.
One of the most interesting things about the science of ergonomics (or perhaps the most frustrating) is the fact that all individuals are of different height, weight, arms and hand size, etc. People have so many different dimensions that the combinations are practically endless. So ergonomics can be seen as a sort of an ongoing convoluted puzzle with missing pieces.
With the immense expansion in the use of computers and associated equipment in the workplace comes the need for less injury and stress to the workers themselves. The long hours many of us spend interacting with our office equipment affect us in many ways - and not always in a positive way.
Unfortunately, gone is the physical variety in our work tasks, as almost all we need is within reach at our desk. And thus comes work-related injuries and other stresses.
Think office-related injuries are a joke? Think again. The 5 main injury sites for an office worker include the neck, shoulders, lower back, wrist and yes, the ankles and legs. If pain is impeding your ability to go to work - that affects your weekly paycheck which in turn, affects your creditors, which in turn affects your whole family's lifestyle.
That's why office furniture manufacturers have stepped in to offer more ergonomically correct chairs and workspace equipment for a healthier work environment.
Aeron chairs were designed for long-term seating for computer work, general office work, and casual or formal meetings by using the principles of ergonomics to minimize back pressure and strain on all areas of the torso.
About The Author:
Reggie Andersen is a home business office advocate. He recommends persistence and a healthy work environment including a strict schedule, good ethics and comfort. Aeron Chairs and Ergonomic Computer Chairs
Generic Medications - The Truth Behind The Myths
These days the subject of generic medications troubles many "anxious about our health government minds ".Generic drugs are unsafe, not helpful as brand names for your diseases , they are made in unautorised facilities ect . Is this the truth or is it just an attempt to favour some american drug manufacturers and pharmacies.
Drug products sold in the United States are approved by the FDA whether they are brand name or generic. "Most people believe that if something costs more, it has to be better quality. In the case of generic drugs, this is not true," says Gary Buehler, Director of FDA's Office of Generic Drugs. "The standards for quality are the same for brand name and generic products."
Health professionals and consumers can be assured that FDA approved generic drugs have met the same rigid standards as the innovator drug. To gain FDA approval, a generic drug must:
· contain the same active ingredients as the innovator drug (inactive ingredients may vary)
· be identical in strength, dosage form, and route of administration
· have the same use indications
· be bioequivalent
· meet the same batch requirements for identity, strength, purity, and quality
be manufactured under the same strict standards of FDA's good manufacturing practice regulations required for innovator products
So we can make the conclusion that: The Generic Drug is a drug which is bioequivalent to a brand name drug with respect to pharmacokinetic and pharmacodynamic properties. Generic medicines must contain the same active ingredient at the same strength as the "innovator" brand, be bioequivalent, and are required to meet the same pharmacopoeial requirements for the preparation. By extension, therefore, generics are identical in dose, strength, route of administration, safety, efficacy, and intended use.
Thus, in some cases, the "generic" product is actually the brand product but inside a different box.
The principal reason for the reduced cost of generic medicines is that these are manufacturered by smaller pharmaceutical companies which do not invest in research and development into new drugs. The significant research and development costs incurred by the large pharmaceutical companies in bringing a new drug to the market is often cited as the reason for the high cost of new agents - they wish to recover these costs before the patent expires.Other reason for high prices is that every year pharmaceutical companies spend billions to market their products .
When a pharmaceutical company first markets a drug, it is usually under a patent that only allows the pharmaceutical company that developed the drug to sell it. This allows the company to recoup the cost of developing that particular drug. It will frequently cost millions of dollars to develop and test a new drug before it is approved for use. After the patent on a drug expires, any pharmaceutical company can manufacture and sell that drug. Since the drug has already been tested and approved, the cost of simply manufacturing the drug will be a fraction of the original cost of testing and developing that particular drug.
So despite the strict standards imposed by the FDA for approval of generic drugs, and their enforcement of these standards, a number of misconceptions about generic drugs persist that we must disprove:
MYTH: Generics take longer to act in the body.
FACT: The firm seeking to sell a generic drug must show that its drug delivers the same amount of active ingredient in the same timeframe as the original product.
MYTH: Generics are not as potent as brand-name drugs.
FACT: FDA requires generics to have the same quality, strength, purity, and stability as brand-name drugs.
MYTH: Generics are not as safe as brand-name drugs.
FACT: FDA requires that all drugs be safe and effective and that their benefits outweigh their risks. Since generics use the same active ingredients and are shown to work the same way in the body, they have the same risk-benefit profile as their brand-name counterparts.
MYTH: Brand-name drugs are made in modern manufacturing facilities, and generics are often made in substandard facilities.
FACT: FDA won't permit drugs to be made in substandard facilities. FDA conducts about 3,500 inspections a year in all firms to ensure standards are met. Generic firms have facilities comparable to those of brand-name firms. In fact, brand-name firms account for an estimated 50 percent of generic drug production. They frequently make copies of their own or other brand-name drugs but sell them without the brand name.
MYTH: Generic drugs are likely to cause more side effects.
FACT: There is no evidence of this. FDA monitors reports of adverse drug reactions and has found no difference in the rates between generic and brand-name drugs.
And finally what we can conclude is that the only "unsafe and unhealthy" thing about generics is the financial loss for the big pharmaceutical companies that want to protect their monopol on our health,despite the necessity of some low income households for effective medical care.
We believe that it takes knowledge & understanding to make wise decisions about the prescription meds that we take. In today's society we are bombarded with huge amounts of confusing information about our health and the prescription drugs that are available. In an effort to clear some of this confusion we strive to provide you with as much information as possible concerning your health and prescription drugs.
So if you can afford to buy brand name medications ,you can help yourself visiting our site http://alto-infotech.com/generic-drugs.html , where we hope that you will find all the drug information that you seek to get rid of your diseases.
A vaccine for the prevention of cervical cancer?
Prof. Kevin Ault, Gynaecologist, from the Emory
University School of Medicine, University of
Iowa, USA has present the results of the last
Study's conclusions are Incredible and it's true;
he told about a vaccine, that is 100 % effective
in preventing the most common types of Cervical
cancer linked to HPV (D3-to see).
The HPV infections are sexually transmitted
diseases which prepare the way for cervical
cancer. We can protect the women against the most
Carcinogenic subtypes (6, 11, 16 and 18 of HPV)
which are the cause of More than 70 % of cervical
cancers.
With optimistic results of the Future II study,
20541 Women from Europe, America and Asia,
between the ages of 16 and 26 years old, was
involved in this extensive project. Of course,
the methodological rules, as a blind Study
compared the quadrivalent vaccine do a placebo.
The Vaccine protected the young women completely
against precancerous Lesions (medium - or
high-grad) of the Cervix related to HPV 16 and
18. The protection result was 100 % of cases! The
sid-effects comes with an extremely low number.
If we see the large number of cases in this
study, the results should be the same if
vaccination is made Available to the public.
We should not forget - the Cervical Cancer is the
second leading cancer in Young women and accounts
for 11 % of Cancers in all women! When the Women
has a common genital Infection with the human
papillomavirus (HPV) and its can result in the
appearance of precancerous lesions of the Cervix
Mucous membrane. For instance, we know that the
connection between HPV infection and cervical
cancer is much stronger than that between smoking
and lung cancer.
How the researcher has got these results? With
this new quadrivalent vaccine for cervical
cancer, the most oncogenic subtypes of HPV can
now be whipped out. One of the first steps is
vaccinating adolescents (D3-"Chronical") Before
they come into contact with the virus; - Results
- No virus, no Lesions - no cancer! Prevention -
the essential part of the combating Cervical
Cancer.
The most oncogenic subtypes of HPV can now be
wiped out thanks to this new quadrivalent
vaccine. The first step is vaccinating
adolescents (D3 - "Chronical") before they come
into contact with the virus; this is a turning
point in the fight against cancer. It is a major
tool in the prevention of precancerous lesions in
the cervix. No virus, no lesions - and if there
are no lesions, that means no cancer. Prevention
is an essential part of the equation when it
comes to combating cervical cancer - that's why
oncologists are so excited about the new Vaccine.
A study conducted with more than 20,000 women has
shown the absolute effectiveness of a vaccine in
the prevention of cervical cancer due to the most
common types of human papillomavirus (HPV).
Oncologists are enthusiastic. It is a rare thing
to hear physicians - and even more so,
oncologists -get excited to the point of speaking
of a "historical breakthrough" after hearing a
presentation from a colleague.
Prof. Thomas Turz, Director of the Institute
Gustave Roussy at the ECCO conference has say -
It is a rare thing to hear physicians - and even
more so, oncologists -get excited to the point of
speaking of a "historical breakthrough" after
hearing a presentation from a colleague. The
Oncologists are enthusiastic.
Health-Service-Online
http://www.cancer-info.info
About The Author:
Fritz Frei make it easy to check out the important details about the diagnoses and test's of the Cervical Cancer. To receive more information's about all cancer -questions - Links and last research NEW's - visit the http://www.cancer-info.info
